QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ABUS

QT69Arbutus Biopharma Corporation
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
4.55
+0.12+2.71%
OverviewShort InterestFilings
ABUSQT69Arbutus Biopharma Corporation·NASDAQ
OverviewShort InterestFilings
4.55+2.71%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E5.34EPS (ttm)
0.83
Insider Own28.54%
Shs Outstand197.54M
Perf Week6.06%
Market Cap875.09MForward P/E-EPS next Y-0.09Insider Trans0.00%Shs Float-Perf Month8.33%
Enterprise Value852.02MPEG0.00EPS next Q-0.02Inst Own-Short Float-Perf Quarter4.12%
Income163.82MP/S4.57EPS this Y-9.57%Inst Trans-Short Ratio-Perf Half Y-0.87%
Sales191.44MP/B3.30EPS next Y-112.00%ROA57.99%Short Interest-Perf YTD-5.41%
Book/sh-P/C-EPS next 5Y-23.18%ROE129.32%52W High5.10 -10.78%Perf Year31.88%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC56.72%52W Low3.04 49.67%Perf 3Y-
Dividend Est.-EV/EBITDA5.30Sales past 3/5Y-Gross Margin99.98%Volatility2.17% 2.68%Perf 5Y-
Dividend TTM-EV/Sales4.45EPS Y/Y TTM-Oper. Margin80.79%ATR (14)0.17Perf 10Y-
Dividend Ex-Date-Quick Ratio54.26Sales Y/Y TTM-Profit Margin83.95%RSI (14)59.24Recom2.20
Dividend Gr. 3/5Y-Current Ratio54.26EPS Q/Q769.23%SMA203.68%Beta1.28Target Price8.50
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA504.33%Rel Volume2.82Prev Close4.43
Employees44LT Debt/Eq-EarningsAug 05SMA2003.11%Avg Volume1.75MPrice4.55
IPO DateJul 26, 2007Option/ShortYes / YesEPS/Sales Surpr.3000.00% 17800.00%Net Debt/EBITDA-0.14Volume4,935,580Change2.71%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-17-22ReiteratedH.C. WainwrightBuy$8.50
Feb-02-22UpgradeJefferiesHold → Buy
Jul-24-20DowngradeBairdOutperform → Neutral
May-19-20UpgradeWedbushNeutral → Outperform
Mar-06-20UpgradeChardan CapitalNeutral → Buy
Feb-05-20UpgradeJMP SecuritiesMarket Perform → Market Outperform
Oct-04-19DowngradeChardan CapitalBuy → Neutral
Oct-16-18UpgradeB. Riley FBRNeutral → Buy
Oct-16-18UpgradeB. Riley SecuritiesNeutral → Buy
Oct-15-18UpgradeWedbushUnderperform → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Insider Trading Volume
$4.95$4.62$4.29$3.96$3.63● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
HASTINGS DAVID CChief Financial OfficerFeb 04 '25Sale3.2822,18372,827159,724Feb 05 12:00 AM
Sims KarenChief Medical OfficerFeb 04 '25Sale3.2819,34863,519106,194Feb 05 12:00 AM
McElhaugh Michael J.Interim President & CEOFeb 04 '25Sale3.2823,79078,1031,481,003Feb 05 12:00 AM
Naftzger J. ChristopherGeneral Counsel and CCOFeb 04 '25Sale3.2811,33337,20686,244Feb 05 12:00 AM
MANCHESTER KEITH SDirectorAug 14 '24Sale3.698,84632,63746,069Aug 16 12:00 AM
MANCHESTER KEITH SDirectorAug 14 '24Option Exercise0.56109,83061,50454,915Aug 16 12:00 AM
Sofia Michael J.Chief Scientific OfficerFeb 02 '24Sale2.319,98223,0831,485,121Feb 05 12:00 AM
HASTINGS DAVID CChief Financial OfficerFeb 02 '24Sale2.319,59322,184181,907Feb 05 12:00 AM
Sims KarenChief Medical OfficerFeb 02 '24Sale2.314,35810,078125,542Feb 05 12:00 AM
McElhaugh Michael J.Interim President & CEOFeb 02 '24Sale2.3110,16423,5041,504,793Feb 05 12:00 AM
Sofia Michael J.Chief Scientific OfficerDec 01 '21Sale5.09200,0001,018,0001,303,403Dec 03 12:00 AM
McElhaugh Michael J.Chief Business OfficerFeb 09 '21Sale5.0020,000100,0001,307,457Feb 10 12:00 AM
McElhaugh Michael J.Chief Business OfficerDec 14 '20Sale5.0040,000200,0321,327,457Dec 16 12:00 AM
McElhaugh Michael J.Chief Business OfficerJul 23 '20Sale5.0120,000100,2001,367,457Jul 27 12:00 AM
Murray Mark J.DirectorNov 28 '18Option Exercise1.3550,00067,500341,396Nov 30 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR